- Business Wire•14 days ago
HemaCare Corporation , a leading provider of human-derived primary blood cells and tissues for biomedical research, has announced a strategic partnership with and investment by a wholly-owned subsidiary of OneBlood, Inc., a not-for-profit blood center based in Florida.
- Business Wire•15 days ago
HemaCare Corporation , a leader in cell and tissue collection, processing, and cell therapy solutions, will be presenting and hosting a roundtable discussion at Phacilitate Cell & Gene Therapy World to be held at the Hyatt Regency Miami in Florida, January 17-20.
- Business Wire•3 months ago
HemaCare Corporation , a leader in cell and tissue collection, processing, and cell therapy solutions, has expanded its global capabilities through a strategic distribution agreement in Korea with Seoul-based AccuResearch Korea, Inc.
HEMA : Summary for HEMACARE CORP - Yahoo Finance
HemaCare Corporation (HEMA)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
|Day's Range||0.00 - 0.00|
|52 Week Range|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-43.75|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|